Published in Atherosclerosis on September 04, 2013
Transcriptional regulation of endothelial arginase 2 by histone deacetylase 2. Arterioscler Thromb Vasc Biol (2014) 0.83
Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis. Oxid Med Cell Longev (2015) 0.77
Effect of passive heat stress on arterial stiffness in smokers versus non-smokers. Int J Biometeorol (2015) 0.77
Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction? Respir Res (2015) 0.75
miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling. PLoS One (2017) 0.75
Modifying effect of intravenous laser therapy on the protein expression of arginase and epidermal growth factor receptor in type 2 diabetic patients. Lasers Med Sci (2016) 0.75
Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature (2002) 3.92
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation (2003) 3.30
Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation (2003) 3.01
Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res (2011) 2.94
Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res (2008) 2.70
Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res (2007) 2.62
Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res (2003) 2.44
Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res (2006) 2.42
Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension (2005) 2.37
Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg (2013) 2.29
Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients. Anesth Analg (2014) 2.04
Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A (2004) 1.91
Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase. Arterioscler Thromb Vasc Biol (2008) 1.90
Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ Res (2004) 1.81
Hypertrophic cardiomyopathy: a review. Anesth Analg (2015) 1.78
Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol (1985) (2009) 1.76
Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension (2013) 1.65
Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. J Appl Physiol (1985) (2006) 1.59
Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium (2002) 1.46
Microgravity-induced changes in aortic stiffness and their role in orthostatic intolerance. J Appl Physiol (1985) (2006) 1.46
Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junction. Hypertension (2004) 1.44
Central sympatholytics prolong survival in experimental sepsis. Crit Care (2009) 1.37
Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc Natl Acad Sci U S A (2006) 1.36
Arginase and vascular aging. J Appl Physiol (1985) (2008) 1.33
Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res (2005) 1.30
Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res (2010) 1.30
Vascular stiffness and increased pulse pressure in the aging cardiovascular system. Cardiol Res Pract (2011) 1.28
Mitochondrial arginase II constrains endothelial NOS-3 activity. Am J Physiol Heart Circ Physiol (2007) 1.21
Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in Rac1-induced oxidative stress. Mol Biol Cell (2005) 1.15
Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension (2011) 1.15
Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries. Circ Res (2010) 1.13
OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis (2010) 1.12
Pulse pressure is an age-independent predictor of stroke development after cardiac surgery. Hypertension (2007) 1.11
Sos-mediated activation of rac1 by p66shc. J Cell Biol (2006) 1.10
Hsp90 regulates NADPH oxidase activity and is necessary for superoxide but not hydrogen peroxide production. Antioxid Redox Signal (2011) 1.09
Effects of verum acupuncture compared to placebo acupuncture on quantitative EEG and heart rate variability in healthy volunteers. J Altern Complement Med (2008) 1.09
Endothelial nitric oxide synthase mediates cutaneous vasodilation during local heating and is attenuated in middle-aged human skin. J Appl Physiol (1985) (2012) 1.09
Review article: implications of vascular aging. Anesth Analg (2011) 1.09
Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care (2009) 1.05
P66shc regulates endothelial NO production and endothelium-dependent vasorelaxation: implications for age-associated vascular dysfunction. J Mol Cell Cardiol (2005) 1.04
Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylation. Free Radic Biol Med (2012) 1.02
Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction. J Urol (2008) 1.02
Increased oxidant activity mediates vascular dysfunction in vibration injury. J Pharmacol Exp Ther (2008) 1.01
Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans. J Physiol (2011) 1.01
Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy. J Physiol (2005) 0.98
Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress. PLoS One (2013) 0.98
Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice. Am J Physiol Heart Circ Physiol (2013) 0.98
Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age. Exp Gerontol (2012) 0.96
Selective fluorescent labeling of S-nitrosothiols (S-FLOS): a novel method for studying S-nitrosation. Nitric Oxide (2008) 0.95
Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 0.95
Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice. Exp Mol Med (2012) 0.95
Exercise, vascular stiffness, and tissue transglutaminase. J Am Heart Assoc (2014) 0.93
Patient safety reporting systems: sustained quality improvement using a multidisciplinary team and "good catch" awards. Jt Comm J Qual Patient Saf (2012) 0.91
Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice. Anesth Analg (2016) 0.90
Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness. Exp Gerontol (2012) 0.90
Development of novel arginase inhibitors for therapy of endothelial dysfunction. Front Immunol (2013) 0.89
Cyclohexanone contamination from extracorporeal circuits impairs cardiovascular function. Am J Physiol Heart Circ Physiol (2009) 0.88
Activation of the cardiac ciliary neurotrophic factor receptor reverses left ventricular hypertrophy in leptin-deficient and leptin-resistant obesity. Proc Natl Acad Sci U S A (2006) 0.88
Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS. Am J Physiol Heart Circ Physiol (2013) 0.88
HZE ⁵⁶Fe-ion irradiation induces endothelial dysfunction in rat aorta: role of xanthine oxidase. Radiat Res (2011) 0.88
Endothelial arginase II and atherosclerosis. Korean J Anesthesiol (2011) 0.87
Evidence for a functional vasodilatatory role for hydrogen sulphide in the human cutaneous microvasculature. J Physiol (2015) 0.87
S-nitrosation of arginase 1 requires direct interaction with inducible nitric oxide synthase. Mol Cell Biochem (2011) 0.87
Nitric oxide regulates tissue transglutaminase localization and function in the vasculature. Amino Acids (2011) 0.86
Increased cross-bridge cycling rate in stunned myocardium. Am J Physiol Heart Circ Physiol (2005) 0.86